Alnylam Pharmaceuticals
ALNY
#429
Rank
A$81.76 B
Marketcap
A$618.86
Share price
2.02%
Change (1 day)
55.45%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company